Searchable abstracts of presentations at key conferences in endocrinology

ea0086pl3 | Society for Endocrinology Dale Medal Lecture | SFEBES2022

Mining the genome for translational gold

McCarthy Mark

Advances in human genetics over the last two decades have discovered genes causal for thousands of monogenic conditions, characterized the mutational landscape of most forms of cancer, and identified tens of thousands of genetic variants influencing common complex traits such as diabetes and Alzheimer’s. Sequence-based diagnostics are now routinely deployed in early-onset genetic disease and in cancers, and the genetic analysis of complex traits has provided many novel an...

ea0015p286 | Reproduction | SFEBES2008

Global adiposity rather than abnormal regional fat distribution characterises women with polycystic ovary syndrome

Barber Thomas , Golding Stephen , Alvey Christopher , Wass John , Karpe Fredrik , Franks Stephen , McCarthy Mark

Background: Fat distribution in women with polycystic ovary syndrome (PCOS) is thought to favour accumulation of abdominal visceral fat, but there has been no systematic comparison of fat distribution in PCOS and normal controls using MRI scanning.Aim: Our aim was to compare distributions of visceral, abdominal subcutaneous and gluteo-femoral subcutaneous adipose tissue in PCOS cases versus control women using a cross-sectional design.<p class="abste...

ea0013p254 | Reproduction | SFEBES2007

Ghrelin is reduced in women with polycystic ovary syndrome and correlates inversely with HOMA IR and testosterone

Barber Thomas M , Casanueva Felipe F , Lage Mary , Franks Stephen , McCarthy Mark I , Wass John AH

Introduction: Ghrelin is a novel peptide involved in the regulation of appetite and energy balance. Dysregulation of ghrelin may play a role in the development of obesity in polycystic ovary syndrome (PCOS). Due to the strong association between BMI and PCOS, we hypothesised that obese women with PCOS have abnormal fasting and post-glucose load ghrelin levels compared with BMI-matched control women.Methods: Datasets included 18 women with PCOS, all with ...

ea0077p54 | Metabolism, Obesity and Diabetes | SFEBES2021

Central adiposity and diabetes are causally associated with kidney stone disease

Lovegrove Catherine , Wiberg Akira , Littlejohns Thomas , Allen Naomi , Turney Benjamin , Mahajan Anubha , McCarthy Mark , Thakker Rajesh , Furniss Dominic , Howles Sarah

Introduction: The pathogenesis of kidney stone disease (KSD) is poorly understood and has been linked to features of metabolic syndrome (MetS). Using conventional and genetic epidemiological analyses we studied associations of MetS phenotypes with risk of KSD.Methods: Multivariate Cox-proportional hazard models were used to assess association of BMI and waist-hip ratio (WHR) with KSD in 492,380 UK Biobank participants. Causal relationships between WHR, B...

ea0050oc4.6 | Adrenal and Steroids | SFEBES2017

Distinct patterns of glucocorticoid metabolism in patients with HNF1A-MODY have the potential to confer a beneficial metabolic phenotype

Juszczak Agata , Gilligan Lorna C. , Hughes Beverly A. , Hassan-Smith Zaki K. , Arlt Wiebke , McCarthy Mark I. , Tomlinson Jeremy W. , Owen Katharine R.

Background and aims: HNF1A-MODY causes monogenic diabetes with a lean, insulin sensitive phenotype. Altered glucocorticoid (GC) metabolism has been implicated in the pathogenesis of type 2 diabetes (T2D) and inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) which regenerates active cortisol from inactive cortisone have been trialled as a therapeutic approach. 11β-HSD1 is down-regulated in hepatocytes from Hnf1a knock-out mice but the role...

ea0050oc4.6 | Adrenal and Steroids | SFEBES2017

Distinct patterns of glucocorticoid metabolism in patients with HNF1A-MODY have the potential to confer a beneficial metabolic phenotype

Juszczak Agata , Gilligan Lorna C. , Hughes Beverly A. , Hassan-Smith Zaki K. , Arlt Wiebke , McCarthy Mark I. , Tomlinson Jeremy W. , Owen Katharine R.

Background and aims: HNF1A-MODY causes monogenic diabetes with a lean, insulin sensitive phenotype. Altered glucocorticoid (GC) metabolism has been implicated in the pathogenesis of type 2 diabetes (T2D) and inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) which regenerates active cortisol from inactive cortisone have been trialled as a therapeutic approach. 11β-HSD1 is down-regulated in hepatocytes from Hnf1a knock-out mice but the role...

ea0086ec1.2 | Early Career Prize Lecture Clinical | SFEBES2022

Central adiposity raises serum calcium concentrations and increases risk of kidney stone disease

Lovegrove Catherine , Besevic Jelena , Wiberg Akira , Lacey Ben , Littlejohns Thomas , Allen Naomi , Goldsworthy Michelle , Kim Jihye , Hannan Fadil , Curhan Gary , Turney Ben , McCarthy Mark , Mahajan Anubja , Thakker Rajesh , Holmes Michael , Furniss Dominic , Howles Sarah

Background: Kidney stone disease (KSD) has been linked to obesity, metabolic syndrome and higher serum calcium concentration (SCa). The mechanisms underlying these associations are uncertain. Using conventional and genetic epidemiological techniques, we aimed to investigate the effects of adiposity on KSD.Methods: Observational associations between adiposity and incident KSD in 479, 405 people from the UK Biobank were assessed. Genome-wide association st...

ea0015p288 | Reproduction | SFEBES2008

Association of variants within the fat mass and obesity-associated (FTO) gene and polycystic ovary syndrome

Barber Thomas , Bennett Amanda , Groves Christopher , Sovio Ulla , Ruokonen Aimo , Martikainen Hannu , Pouta Anneli , Hartikainen Anna-Liisa , Elliott Paul , Lindgren Cecilia , Freathy Rachel , Koch Kirsten , Ouwehand Willem , Karpe Fredrik , Conway Gerard , Wass John , Jarvelin Marjo-Riitta , Franks Stephen , McCarthy Mark

Background: Obesity plays an important role in the aetiology of polycystic ovary syndrome (PCOS). Variants in the fat-mass and obesity-associated (FTO) gene have recently been shown to influence adiposity and predispose to common obesity (Frayling et al., Science 2007 316 889–894).Aim: Our aim was to establish whether FTO variants are also implicated in PCOS-susceptibility.Methods: A genetic ...